Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Weekly channel feed
The top 100 biopharma VCs, Bob Bradway places $2B bet in cancer, gene editing pioneer's new big idea, and more
5 years ago
The future of mRNA, J&J's vaccine adcomm, Merck's $1.85B autoimmune bet and more
5 years ago
A gene therapy leader stumbles, Medicxi's splashy 10-in-1 startup play, a radical HIV cure gets its shot, and biopharma's new top 50
5 years ago
First page
Previous page
7
8
9
10
